All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0643 | Anti-UBE3A (CBFYE-0010) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0010 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0644 | Anti-UBE3A (CBFYE-1682) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1682 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0645 | Anti-UBE3A (CBFYE-1683) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1683 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3896 | Anti-UBE3A (CBFYE-0010) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0010 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3897 | Anti-UBE3A (CBFYE-1682) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1682 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3898 | Anti-UBE3A (CBFYE-1683) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-1683 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY033 | Anti-UBE3A (1A10) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1A10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY034 | Anti-UBE3A (1A2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1A2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1673 | Anti-UBE3A(1A10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1A10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1674 | Anti-UBE3A(1A2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1A2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION